Cargando…
Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity
In earlier studies, galectin-9 (Gal-9) was identified as a multifaceted player in both adaptive and innate immunity. Further, Gal-9 had direct cytotoxic and tumor-selective activity towards cancer cell lines of various origins. In the current study, we identified that treatment with Gal-9 triggered...
Autores principales: | Ustyanovska Avtenyuk, Natasha, Choukrani, Ghizlane, Ammatuna, Emanuele, Niki, Toshiro, Cendrowicz, Ewa, Lourens, Harm Jan, Huls, Gerwin, Wiersma, Valerie R., Bremer, Edwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772786/ https://www.ncbi.nlm.nih.gov/pubmed/35052746 http://dx.doi.org/10.3390/biomedicines10010066 |
Ejemplares similares
-
Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance
por: Choukrani, Ghizlane, et al.
Publicado: (2023) -
CD24 Is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma
por: Freile, Jimena Álvarez, et al.
Publicado: (2022) -
The Neutrophil: The Underdog That Packs a Punch in the Fight against Cancer
por: Ustyanovska Avtenyuk, Natasha, et al.
Publicado: (2020) -
Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine
por: Visser, Nienke, et al.
Publicado: (2021) -
Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
por: He, Yuan, et al.
Publicado: (2019)